From KCRW in Santa Monica and PRI, Public Radio International, this is To the Point.

Angelina Jolie, breast cancer and radical surgery.

Hello again, I'm Aron Alney, and this is To the Point from Public Radio International,

a daily look at the issues Americans care about most. Angelina Jolie has started a new conversation about breast cancer and what to do

if genetic testing shows a high risk for the disease. Experts say the most important lesson is that

even the testing is not for everyone, let alone a double mastectomy. There's concern that many women

will demand more treatment than they need, partly because

of the pink ribbon culture and the medical industry.

We'll hear more about the agonizing decisions women might be faced with all on their own.

On reporter's notebook later on, the pros and cons of creating human embryonic stem cells.

First, here's the news.

Listen to KCRW's 24-hour all-news channel.

Stream BBC World Service, NPRW programs.

Continuous coverage and accessible via our smartphone app or online at kCRW.

Support for To The Point comes from the members of KCRW and from the Public Radio International

Program Fund. Hello again, Warren Alney, back with To the Poet.

Angelina Jolie's revelation of her preventive double mastectomy is raising new fears, as well as some reassurance.

Even those who applaud her courage worry about overreaction. We'll hear about that. On reporter's

notebook, the newly announced ability to clone human stem cells could transform the possibility for treating many diseases.

It also raises legal issues and troubling moral questions.

First is news update.

At the White House today, President Obama said firing the head of the IRS isn't enough.

...